Skip to main content

Latest MRFR Brief on metastases spinal tumor Industry is growing moderately in Upcoming Years


The global metastases spinal tumor Industry is growing moderately, and it is expected to grow at the same pace over the forecast period.

Early diagnosis can provide better treatment management of this disorder. Major diagnostic solution provider companies are engaged in developing and launching new medical imaging devices. Introduction and rapid adoption of advanced diagnostic devices are driving the market growth.

The global market of metastases spinal tumor was around USD 1241.5 million in 2016 and is expected to reach USD 1547.8 million by 2023 at a projected CAGR of 3.2%.


Competitive Analysis:
Some of the key players in this market are –
  • Hoffmann-La Roche Ltd (Switzerland)
  • Amgen Inc. (US)
  • Novartis AG(Switzerland)
  • Abbott (US)
  • Beckman Coulter Inc. (US)
  • Debiopharm Group (Switzerland)
  • AbbVie Inc. (US)
  • Bayer AG (Germany)
  • and others.
Market Segments

The global metastases spinal tumor Industry is segmented on the basis of type, which comprise extradural, metastatic spinal tumors of the bone, and others.

On the basis of diagnosis - laboratory tests, imaging tests, biopsy, and others. Imaging tests includes X-Ray, Computed Tomography (CT scan), Magnetic Resonance Imaging (MRI scan), Angiography, F-18 fluorodeoxyglucose positron emission tomography, and others. Biopsy is sub-segmented into percutaneous needle biopsy, open incisional and excisional biopsy, and others.

On the basis of treatments - non-operative treatment, surgical treatment, and others. Non operative treatment is sub-segmented into medications, radiation therapy, ablation, chemotherapy, and others. Medications includes anti-inflammatory drugs, narcotics (opioids), corticosteroids, rankl inhibitors and bisphosphonates, and others. Ablation is further sub-segmented into radiofrequency ablation, cryoablation, and others. Surgical treatment is further sub-segmented into minimally invasive surgery, open surgery, and others. Minimally invasive surgery is sub-segmented into vertebral fracture treatments, transarterial chemoembolization, and others. Vertebral fracture treatments is further sub-segmented into vertebroplasty, kyphoplasty (vertebral augmentation), and others. Open surgery includes spinal stabilization surgery, spinal decompression surgery, and others.

On the basis of end user, - hospitals & clinics, ambulatory surgery centers, academic institutes, research centers, and others.



Regional Analysis:

The global metastases spinal tumor Industry is consist of four regions: America, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominate this market, particularly North America due to ongoing oncology research and clinical trials. American pharmaceutical giants such as Amgen Inc., AbbVie Inc., and others are dominating the global healthcare sector, and these companies are investing a large amount of money for research. Upcoming healthcare bill in the US is expected to lead the market growth in this region.

Increasing prevalence of metastases spinal tumor drives the European market. Moreover, availability of skilled medical professional and advanced healthcare facilities add fuel to the market growth. This region is mainly divided into Eastern Europe and Western Europe. Though Western Europe dominates this market, but it is now a saturated, while Eastern Europe is showing significant growth in this market.

Asia Pacific homes more than half of the world’s population. Increasing healthcare expenditure, government support to improve public health and growing awareness are driving this market.

Due to lack of awareness about this disorder and limited access to the healthcare facilities, the Middle East & Africa region is expected to have the least growth during the forecast period

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312

Comments

Popular posts from this blog

Chatbots in Healthcare Market Research Report by Top Industry Vendors and Applications Scenario till 2023

Chatbots in Healthcare Market Overview Healthcare chatbots are programs which assist patients with queries. This reduces the burden on the clinical staff and lets them focus on their jobs. Automation of various workflow processes in the healthcare sector is likely to propel the demand for these virtual assistants. The global Chatbots in Healthcare Market is expected to touch USD 316.85 million by 2023 at 21.10% CAGR over the forecast period (2018-2023), as per Market Research Future (MRFR). It stood at USD 100.46 million in 2017. Rise of chronic diseases coupled with lack of medical experts to handle queries are main drivers of the market. For instance, cancer patients used chatbots to gain rapid assistance regarding medication and their adverse effects.  The  Chatbots in Healthcare Market   Free Growth Sample will provide valuable insight with an emphasis on the global market including some of the  major players  such As, ...

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Growth Drivers, Restraints and Opportunities, Forecast To 2025

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size Research Report: Information by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 Global  Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size  Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. Some of the key players operating for the global market analysis are  Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La R...

Kidney Dialysis Equipment Market Business Opportunities, Recent Updates and Developments 2019 To 2023

Kidney Dialysis Equipment Market  Development Opportunities and Global Industry Share Analysis by Top Leading Competitors – Latest MRFR Brief 2020 kidney dialysis equipment market is expected to witness tremendous growth owing to rising factors leading to kidney failure. Key factors such as growing acidosis, heart failure, change in sedentary lifestyle, uremic encephalopathy, vomiting, and loss of appetite leading to weight loss are contributing towards the growth of the market. According to the BCC Research report, the global market for kidney dialysis equipment is likely to grow at a CAGR of 5.7% from an assessed USD 16.5 billion in 2017, However, factors such as the high cost of dialysis procedures, expensive treatments, and rules and regulations associated with kidney dialysis equipment procedures are expected to restrict the market growth during the forecast period.. Some of the key players in the kidney dialysis equipment market are  Fresenius Medical Care AG ...